Evidence map›Paper›PMID 23847438›Full record

ArticleInternational journal of biological sciences2013

Circulating matrix metalloproteinase-2 and -9 enzyme activities in the children with ventricular septal defect.

Kun-Shan Cheng, Yan-Chiou Liao, Mu-Yuan Chen, Tang-Ching Kuan, Yi-Han Hong, Li Ko, Wen-Yeh Hsieh, Chien-Liang Wu, Ming-Ren Chen, Chih-Sheng Lin

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A review of spontaneous closure of ventricular septal defect.Proceedings (Baylor University. Medical Center) · 2015
    Review
  8. Article
  9. Factors influencing the spontaneous closure of ventricular septal defect in infants.International journal of clinical and experimental pathology · 2015
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kun-Shan ChengDepartment of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Yan-Chiou Liao
Mu-Yuan Chen
Tang-Ching Kuan
Yi-Han Hong
Li Ko
Wen-Yeh Hsieh
Chien-Liang Wu
Ming-Ren Chen
Chih-Sheng Lin
National Yang Ming Chiao Tung University · TWMackay Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ventricular septal defect (VSD) is the most common form of congenital heart diseases. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases involved in causal cardiac tissue remodeling. We studied the changes of circulating MMP-2 and MMP-9 activities in the patients with VSD severity and closure. There were 96 children with perimembranous VSD enrolled in this study. We assigned the patients into three groups according to the ratio of VSD diameter/diameter of aortic root (Ao). They were classified as below: Trivial (VSD/Ao ratio ≤ 0.2), Small (0.2 < VSD/Ao ≤ 0.3) and Median (0.3 < VSD/Ao) group. Plasma MMP-2 and MMP-9 activities were assayed by gelatin zymography. There was a significant higher MMP-2 activity in the VSD (Trivial, Small and Median) groups compared with that in Control group. The plasma MMP-9 activity showed a similar trend as the findings in MMP-2 activity. After one year follow-up, a significant difference in the MMP-9 activity was found between VSD spontaneous closure and non-closure groups. In conclusion, a positive trend between the severity of VSD and activities of MMP-2 and MMP-9 was found. Our data imply that MMP-2 and MMP-9 activities may play a role in the pathogenesis of VSD.

Indexed as

Case-Control StudiesChildEnzyme-Linked Immunosorbent AssayHeart Septal Defects, VentricularHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-3Matrix Metalloproteinase 2Matrix Metalloproteinase 9TIMP3 protein, humanTissue Inhibitor of Metalloproteinase-3Matrix metalloproteinase-2Matrix metalloproteinase-9Tissue inhibitor of metalloproteinase-3Ventricular septal defect

Identifiers

PMID23847438
PMCPMC3708036
OpenAlexW2104235332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.